An archive of all Pfizer press releases issued in the United States. Intended as a reference for U.S. investors and journalists.
http://pfizer.newshq.businesswire.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
2.7 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
3
SITE IP
204.8.173.158
LOAD TIME
2.654 sec
SCORE
6.2
Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company | | pfizer.newshq.businesswire.com Reviews
https://pfizer.newshq.businesswire.com
An archive of all Pfizer press releases issued in the United States. Intended as a reference for U.S. investors and journalists.
pfizer.newshq.businesswire.com
Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest resear
http://pfizer.newshq.businesswire.com/node/4357
Research and Development at Pfizer. Conducting Research and Clinical Trials. Working with Health Care Professionals. Material Safety Data Sheets. Contact Pfizer Media Relations. Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia. Contact Pfizer Media Relations. Monday, December 5, 2016 8:00 am EST. NEW YORK- ( BUSINESS WIRE. Osutinib trial in F. Irst line chr O. Atment) trial demon...
Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
http://pfizer.newshq.businesswire.com/node/4391
Research and Development at Pfizer. Conducting Research and Clinical Trials. Working with Health Care Professionals. Material Safety Data Sheets. Contact Pfizer Media Relations. Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts. Contact Pfizer Media Relations. Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts. Tuesday, January 3, 2017 11:00 am EST. NEW YORK- ( BUSINESS WIRE. You can also listen to the conference c...
FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
http://pfizer.newshq.businesswire.com/node/4379
Research and Development at Pfizer. Conducting Research and Clinical Trials. Working with Health Care Professionals. Material Safety Data Sheets. Contact Pfizer Media Relations. FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE (palbociclib) in HR , HER2- Metastatic Breast Cancer. Contact Pfizer Media Relations. FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE (palbociclib) in HR , HER2- Metastatic Breast Cancer. Wednesday, December 21, 2016 8:00 am EST. Since its intro...
LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
http://pfizer.newshq.businesswire.com/press-release/lyrica-pregabalin-phase-3-trial-pediatric-epilepsy-meets-primary-endpoint
Research and Development at Pfizer. Conducting Research and Clinical Trials. Working with Health Care Professionals. Material Safety Data Sheets. Contact Pfizer Media Relations. LYRICA (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint. Contact Pfizer Media Relations. LYRICA (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint. Thursday, December 1, 2016 8:00 am EST. Forward-Looking Information and Factors That May Affect Future Results". NEW YORK- ( BUSINESS WIRE.
Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab) | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutic
http://pfizer.newshq.businesswire.com/press-release/pfizer-announces-positive-top-line-results-comparative-reflections-b538-02-study-pf-06
Research and Development at Pfizer. Conducting Research and Clinical Trials. Working with Health Care Professionals. Material Safety Data Sheets. Contact Pfizer Media Relations. Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira 1 (adalimumab). Contact Pfizer Media Relations. Marks Pfizer’s third proposed biosimilar pipeline molecule. To report positive top-line data results within the past four months. REFLECTIONS B...
TOTAL PAGES IN THIS WEBSITE
20
Pfizer Italia
Questo sito utilizza cookie di profilazione propri e di altri siti per inviare all'utente comunicazioni commerciali in linea con le preferenze manifestate durante la navigazione. Per ulteriori informazioni sui cookie che potrebbero essere installati navigando sul sito www.pfizer.it. O per negare il consenso a tutti o alcuni cookie, CLICCARE QUI. Pfizer informa che, accedendo al sito www.pfizer.it. L'utente manifesta la propria accettazione all'uso dei cookie. Modelli D.Lgs.231/01. Vicini di salute : Pfiz...
Pfizer Jobs
City, state, country. Job title, keywords. View All Jobs (. Retail Rep 2 star. Associate I, DM. Principal Scientist, Computational Biology. Director, Repository Management Lead. Tecnico garantia de Calidad (Temp hasta noviembre). Sr Manager Compensation and Benefits APAC. QC Microbiology Laboratory Technologist. Associate Market Access Director. Representante Comercial I (Salvador/BA). Production Supervisor, SVP R1 Solutions. Tecnico garantia de Calidad (Temp hasta diciembre). Rocky Mount, NC (97).
IIS Windows Server
Pfizer
Šis domenas dar nenaudojamas. Jis priparkuotas portale Dom.lt. Informacija apie Pfizer.lt.
pfizer.newshq.businesswire.com
Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company |
Research and Development at Pfizer. Conducting Research and Clinical Trials. Working with Health Care Professionals. Material Safety Data Sheets. Contact Pfizer Media Relations. Contact Pfizer Media Relations. Recent Pfizer Press Releases. Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira 1 (adalimumab). 1/5/17 8:30 am EST. Marks Pfizer’s third proposed biosimilar pipeline molecule. NEW YORK- ( BUSINESS WIRE. Pfizer...
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. For more information please contact . Lets you run Windows on any Intel-based Mac without rebooting! The best solution for running Windows, Linux, or any of many other operating systems alongside OS X. The most efficient server virtualization technology.
Home | Pfizer. Samen werken aan een gezondere wereld
GET TO KNOW US. Ontwikkelen, maken en verkopen: Geneesmiddelen en vaccins. Ontwikkelen van nieuwe medicijnen: Kennis, ervaring en expertise. Investeren in onderzoek en ontwikkeling: Investeren in een betere toekomst. Belangrijke maatschappelijke bijdrage: Levens redden en de levensverwachting verlengen. Bijdragen aan groei en productiviteit: Verbeterde productiviteit dankzij geneesmiddelen. Bijdragen aan duurzaamheid zorgsysteem: Een efficiënt en productief gezondheidssysteem. GET TO KNOW US. Een efficië...
Pfizer
Norges beste arbeidplass 2015. Pfizer på sosiale medier. Om legemidler og medisiner. Ulike måter å ta legemidler på. Å ta flere legemidler samtidig. Å avslutte en behandling. Legemiddelinfo rett på mobilen. Slik bruker du legemidler riktig. For pasienter og pårørende. Høyt kolesterol kan øke risikoen for hjerte og karsykdom, men det er mulig å forebygge. Les mer her. Røykfri med råd fra legen. Det er mulig å lykkes med røykeslutt, les mer her. Pfizer på sosiale medier. Pfizer markerer verdens blodproppdag.
Pfizer
Образовательный проект Pfizer - СПХФА "Больше, чем образование". Образовательный проект Pfizer - СПХФА "Больше, чем образование". В июне 2011 года Правительство Санкт-Петербурга, Санкт-Петербургская государственная химико-фармацевтическая академия, компании Pfizer и Биокад заключили соглашения по разработке и запуску программы повышения квалификации и профессионального развития для студентов и специалистов фармацевтической отрасли под названием. БОЛЬШЕ, ЧЕМ ОБРАЗОВАНИЕ. Принципы организации фармацевтичес...
pfizer.pl
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
